IHC Algorithm Enriches Equivocal HER2 Breast Cancers but Requires Confirmatory Testing
A proof-of-concept study demonstrates that an automated immunohistochemistry algorithm enriches for HER2 amplification in equivocal breast cancers but remains insufficiently ...

